MOVE Medacta Group

Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution

Medacta Group SA / Key word(s): Partnership
Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution

29.08.2024 / 19:00 CET/CEST


MEDIA RELEASE

Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution

CASTEL SAN PIETRO, 29 August 2024 - Medacta Group SA (“Medacta”, SIX:MOVE), announces its partnership with THINK Surgical®, an innovative leader in the field of open platform orthopedic robots, to provide its robotic, wireless hand-held TMINI® Miniature Robotic System for total knee replacement surgery supporting both GMK Sphere and GMK SpheriKA, the world’s first knee implant designed specifically for Kinematic Alignment, a personalized and innovative technique that significantly increases patient satisfaction and facilitates a return to a healthy, active life1.

“I am pleased to announce our collaboration with THINK Surgical in the US Market,” stated Matt Goudy, Managing Director and President of Medacta USA. “This partnership marks another step forward in our commitment to offering cutting-edge technologies that drive sustainable innovation forward and enhance our ability to deliver personalized solutions for surgeons and patients worldwide.”

The THINK Surgical TMINI system, when combined with GMK Sphere and GMK SpheriKA, adds further value to MyKA, the most comprehensive platform to safely and reproducibly perform Kinematic Alignment total knee replacement. Moreover, it complements the Medacta portfolio of enabling technologies designed for knee arthroplasty, providing surgeons with a robotic-assisted  option to execute meticulous 3D CT-based preoperative planning. This system will complement the MySolutions Personalized Ecosystem, a network of advanced digital solutions designed to improve patient outcomes and healthcare efficiency during the entire episode of care. This includes the flagship NextAR Augmented Reality Surgical Platform, a unique system that leverages patient-specific data to complement operative workflows, as well as MyKnee Patient Matched Technology and Efficiency KneePack, which is successfully used to provide patient-specific cutting blocks, single-use instrumentation, and implants in a single, one-time use kit.

While the MySolutions Ecosystem remains central to Medacta’s technology focus, the partnership with THINK Surgical will allow for the continued evaluation of robotics in the U.S. market, as well as Medacta’s specialized focus in the rapidly growing Ambulatory Surgery Center segment, in particular.

All Medacta products are supported by the comprehensive, tailored educational offerings provided by the M.O.R.E. Institute. With an international network of expert surgeons, the M.O.R.E. Institute is at the forefront of education with personalized, high-level educational pathways. With Medacta, the surgeon is never alone while discovering new technologies.

Contact

Medacta International SA
Gianluca Olgiati     
Group Vice President Marketing  
Phone: 0

About Medacta

is a key global player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 60 countries. Follow us on , ,  and .

RELATED TRADEMARKS

Medacta Group Related Trademarks are registered at least in Switzerland. The products and services listed below may not be all-inclusive, and other Medacta products and services not listed below may be covered by one or more trademarks. The below products and services may be covered by additional trademarks not listed below. Note that Swiss trademarks may have foreign counterparts. MySolutions™ Personalized Ecosystem, NextAR™, GMK® SpheriKA, GMK® Sphere, MyKA™, MyKnee®.

THINK Surgical® and TMINI® are trademarks of THINK Surgical, Inc.

REFERENCE

[1] Niki Y, Nagura T, Kobayashi S, Udagawa K, Harato K. Who Will Benefit From Kinematically Aligned Total Knee Arthroplasty? Perspectives on Patient-Reported Outcome Measures. J Arthroplasty. 2020 Feb;35(2):438-442.e2. doi: 10.1016/j.arth.2019.09.035. Epub 2019 Sep 26. PMID: 31668528.


Additional features:

File:


End of Media Release


Language: English
Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone:
E-mail:
Internet:
ISIN: CH0468525222
Listed: SIX Swiss Exchange
EQS News ID: 1977995

 
End of News EQS News Service

1977995  29.08.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1977995&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
29/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medacta Group

Maria Vara ... (+3)
  • Maria Vara
  • Oscar Haffen Lamm
  • Valliant Campagne

Suspension of coverage

From 2nd of June we are suspending coverage of companies below due to a reallocation of resources. Our prior estimates should no longer be used as an indicator for the company moving forward.INNATE PHARMAINVENTIVAMEDACTAMEDARTISONWARD MEDICALVALNEVA

Maria Vara
  • Maria Vara

Medacta: model update - Buy rating reiterated, unchanged CHF160 PT

We update our model following the publication of the company's annual report. No changes have been applied to our revenue forecast as FY 2024 results and 2025 guidance are aligned with our estimates. On the P&L, we have softened our S&M expenses expectation as these stood more towards 35.5%

 PRESS RELEASE

Medacta publishes 2025 Annual General Meeting invitation

Medacta Group SA / Key word(s): AGMEGM Medacta publishes 2025 Annual General Meeting invitation 08.04.2025 / 10:00 CET/CEST Press Release                     Medacta publishes 2025 Annual General Meeting invitation  CASTEL SAN PIETRO, 8 April 2025 – Medacta Group SA (“Medacta”, SIX:MOVE) published today the invitation to the Annual General Meeting (“AGM”) which will take place on Wednesday, 7 May 2025 at 11.00 a.m. at the Group premises in Via alla Rossa 6, Rancate, Switzerland. Shareholders can register to attend the Annual General Meeting in person but will also be abl...

Maria Vara
  • Maria Vara

Medacta: Exceptional FY2024 to fuel sustainable growth, adj. EBITDA hi...

Medacta reported preliminary unaudited FY 2024 revenue in early February; hence, the EUR590.6m figure was not a surprise. Nonetheless, we may highlight again that all four business lines delivered above the market growth with double-digit cc gains with a broad base geographical contribution. Gross

Maria Vara
  • Maria Vara

Medacta: expanding SportsMed footprint with Parcus Medical acquisition

Medacta expands its SportMeds footprint by acquiring Parcus Medical, a distinguished player with a diverse product family in sports medicine spanning the shoulder, knee, hip, and foot & ankle, with FY2024 unaudited revenues of USD16m. The acquisition not only expands Medacta's offering but also

ResearchPool Subscriptions

Get the most out of your insights

Get in touch